INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯，很快，已经接收3篇了，友好的期刊和审稿人，当然提出的修改意见很中肯，希望该期刊志能尽快跨入一区，突破5分，还会支持的！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239073, encodeId=e6a722390e3ed, content=9月28号Under Review，11月25日还在找审稿人，整整两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50061907645, createdName=ms4255114797740350, createdTime=Mon Nov 25 15:38:06 CST 2024, time=2024-11-25, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2238647, encodeId=67a7223864e06, content=审稿速度:6.0 经验分享：二审2个月，找了第3个审稿人，审的最初投稿版本，用前两个审稿人的问题给我拒了，去哪说理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6a8350383, createdName=ms6000001780597345, createdTime=Sat Nov 23 12:21:10 CST 2024, time=2024-11-23, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154856, encodeId=0d682154856c5, content=偏重的研究方向：蛋白;生物材料 经验分享：请问大修是一个审稿人意见，已经返修回去，还会邀请审稿人出新的意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dbfa2580368, createdName=125a246am56暂无昵称, createdTime=Sun Aug 27 23:15:58 CST 2023, time=2023-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2229803, encodeId=e98722298037a, content=短期扩刊，这两年收稿量暴增。大概率会预警或者on hold。慎投，毕竟一篇文章不容易~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41145088522, createdName=145ca8c9m65(暂无昵称), createdTime=Tue Oct 08 14:02:47 CST 2024, time=2024-10-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2229468, encodeId=51942229468d7, content=这个杂志出版量太大，有可能on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd578280026, createdName=ms4000000794744668, createdTime=Sat Oct 05 22:55:30 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227366, encodeId=1fb3222e36632, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：皮肤 经验分享：JNB拒稿后投的，一审大约3个月，1个审稿人小修，修回2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Sep 24 10:01:03 CST 2024, time=2024-09-24, status=1, ipAttribution=上海)]

2023-09-11 Markxiao 来自香港

偏重的研究方向：分子生物学
经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢

89 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯，很快，已经接收3篇了，友好的期刊和审稿人，当然提出的修改意见很中肯，希望该期刊志能尽快跨入一区，突破5分，还会支持的！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239073, encodeId=e6a722390e3ed, content=9月28号Under Review，11月25日还在找审稿人，整整两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50061907645, createdName=ms4255114797740350, createdTime=Mon Nov 25 15:38:06 CST 2024, time=2024-11-25, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2238647, encodeId=67a7223864e06, content=审稿速度:6.0 经验分享：二审2个月，找了第3个审稿人，审的最初投稿版本，用前两个审稿人的问题给我拒了，去哪说理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6a8350383, createdName=ms6000001780597345, createdTime=Sat Nov 23 12:21:10 CST 2024, time=2024-11-23, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154856, encodeId=0d682154856c5, content=偏重的研究方向：蛋白;生物材料 经验分享：请问大修是一个审稿人意见，已经返修回去，还会邀请审稿人出新的意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dbfa2580368, createdName=125a246am56暂无昵称, createdTime=Sun Aug 27 23:15:58 CST 2023, time=2023-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2229803, encodeId=e98722298037a, content=短期扩刊，这两年收稿量暴增。大概率会预警或者on hold。慎投，毕竟一篇文章不容易~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41145088522, createdName=145ca8c9m65(暂无昵称), createdTime=Tue Oct 08 14:02:47 CST 2024, time=2024-10-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2229468, encodeId=51942229468d7, content=这个杂志出版量太大，有可能on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd578280026, createdName=ms4000000794744668, createdTime=Sat Oct 05 22:55:30 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227366, encodeId=1fb3222e36632, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：皮肤 经验分享：JNB拒稿后投的，一审大约3个月，1个审稿人小修，修回2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Sep 24 10:01:03 CST 2024, time=2024-09-24, status=1, ipAttribution=上海)]

2025-01-19 1467d47dm55暂无昵称来自江苏省

一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！

12 0

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯，很快，已经接收3篇了，友好的期刊和审稿人，当然提出的修改意见很中肯，希望该期刊志能尽快跨入一区，突破5分，还会支持的！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239073, encodeId=e6a722390e3ed, content=9月28号Under Review，11月25日还在找审稿人，整整两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50061907645, createdName=ms4255114797740350, createdTime=Mon Nov 25 15:38:06 CST 2024, time=2024-11-25, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2238647, encodeId=67a7223864e06, content=审稿速度:6.0 经验分享：二审2个月，找了第3个审稿人，审的最初投稿版本，用前两个审稿人的问题给我拒了，去哪说理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6a8350383, createdName=ms6000001780597345, createdTime=Sat Nov 23 12:21:10 CST 2024, time=2024-11-23, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154856, encodeId=0d682154856c5, content=偏重的研究方向：蛋白;生物材料 经验分享：请问大修是一个审稿人意见，已经返修回去，还会邀请审稿人出新的意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dbfa2580368, createdName=125a246am56暂无昵称, createdTime=Sun Aug 27 23:15:58 CST 2023, time=2023-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2229803, encodeId=e98722298037a, content=短期扩刊，这两年收稿量暴增。大概率会预警或者on hold。慎投，毕竟一篇文章不容易~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41145088522, createdName=145ca8c9m65(暂无昵称), createdTime=Tue Oct 08 14:02:47 CST 2024, time=2024-10-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2229468, encodeId=51942229468d7, content=这个杂志出版量太大，有可能on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd578280026, createdName=ms4000000794744668, createdTime=Sat Oct 05 22:55:30 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227366, encodeId=1fb3222e36632, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：皮肤 经验分享：JNB拒稿后投的，一审大约3个月，1个审稿人小修，修回2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Sep 24 10:01:03 CST 2024, time=2024-09-24, status=1, ipAttribution=上海)]

2023-10-12 superzera 来自广东省

投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等

99 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯，很快，已经接收3篇了，友好的期刊和审稿人，当然提出的修改意见很中肯，希望该期刊志能尽快跨入一区，突破5分，还会支持的！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239073, encodeId=e6a722390e3ed, content=9月28号Under Review，11月25日还在找审稿人，整整两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50061907645, createdName=ms4255114797740350, createdTime=Mon Nov 25 15:38:06 CST 2024, time=2024-11-25, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2238647, encodeId=67a7223864e06, content=审稿速度:6.0 经验分享：二审2个月，找了第3个审稿人，审的最初投稿版本，用前两个审稿人的问题给我拒了，去哪说理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6a8350383, createdName=ms6000001780597345, createdTime=Sat Nov 23 12:21:10 CST 2024, time=2024-11-23, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154856, encodeId=0d682154856c5, content=偏重的研究方向：蛋白;生物材料 经验分享：请问大修是一个审稿人意见，已经返修回去，还会邀请审稿人出新的意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dbfa2580368, createdName=125a246am56暂无昵称, createdTime=Sun Aug 27 23:15:58 CST 2023, time=2023-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2229803, encodeId=e98722298037a, content=短期扩刊，这两年收稿量暴增。大概率会预警或者on hold。慎投，毕竟一篇文章不容易~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41145088522, createdName=145ca8c9m65(暂无昵称), createdTime=Tue Oct 08 14:02:47 CST 2024, time=2024-10-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2229468, encodeId=51942229468d7, content=这个杂志出版量太大，有可能on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd578280026, createdName=ms4000000794744668, createdTime=Sat Oct 05 22:55:30 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227366, encodeId=1fb3222e36632, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：皮肤 经验分享：JNB拒稿后投的，一审大约3个月，1个审稿人小修，修回2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Sep 24 10:01:03 CST 2024, time=2024-09-24, status=1, ipAttribution=上海)]

2020-03-29 ms7269483029162029

嗯，很快，已经接收3篇了，友好的期刊和审稿人，当然提出的修改意见很中肯，希望该期刊志能尽快跨入一区，突破5分，还会支持的！

130 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯，很快，已经接收3篇了，友好的期刊和审稿人，当然提出的修改意见很中肯，希望该期刊志能尽快跨入一区，突破5分，还会支持的！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239073, encodeId=e6a722390e3ed, content=9月28号Under Review，11月25日还在找审稿人，整整两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50061907645, createdName=ms4255114797740350, createdTime=Mon Nov 25 15:38:06 CST 2024, time=2024-11-25, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2238647, encodeId=67a7223864e06, content=审稿速度:6.0 经验分享：二审2个月，找了第3个审稿人，审的最初投稿版本，用前两个审稿人的问题给我拒了，去哪说理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6a8350383, createdName=ms6000001780597345, createdTime=Sat Nov 23 12:21:10 CST 2024, time=2024-11-23, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154856, encodeId=0d682154856c5, content=偏重的研究方向：蛋白;生物材料 经验分享：请问大修是一个审稿人意见，已经返修回去，还会邀请审稿人出新的意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dbfa2580368, createdName=125a246am56暂无昵称, createdTime=Sun Aug 27 23:15:58 CST 2023, time=2023-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2229803, encodeId=e98722298037a, content=短期扩刊，这两年收稿量暴增。大概率会预警或者on hold。慎投，毕竟一篇文章不容易~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41145088522, createdName=145ca8c9m65(暂无昵称), createdTime=Tue Oct 08 14:02:47 CST 2024, time=2024-10-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2229468, encodeId=51942229468d7, content=这个杂志出版量太大，有可能on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd578280026, createdName=ms4000000794744668, createdTime=Sat Oct 05 22:55:30 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227366, encodeId=1fb3222e36632, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：皮肤 经验分享：JNB拒稿后投的，一审大约3个月，1个审稿人小修，修回2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Sep 24 10:01:03 CST 2024, time=2024-09-24, status=1, ipAttribution=上海)]

2024-11-25 ms4255114797740350 来自青海省

9月28号Under Review，11月25日还在找审稿人，整整两个月了

69 0

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯，很快，已经接收3篇了，友好的期刊和审稿人，当然提出的修改意见很中肯，希望该期刊志能尽快跨入一区，突破5分，还会支持的！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239073, encodeId=e6a722390e3ed, content=9月28号Under Review，11月25日还在找审稿人，整整两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50061907645, createdName=ms4255114797740350, createdTime=Mon Nov 25 15:38:06 CST 2024, time=2024-11-25, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2238647, encodeId=67a7223864e06, content=审稿速度:6.0 经验分享：二审2个月，找了第3个审稿人，审的最初投稿版本，用前两个审稿人的问题给我拒了，去哪说理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6a8350383, createdName=ms6000001780597345, createdTime=Sat Nov 23 12:21:10 CST 2024, time=2024-11-23, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154856, encodeId=0d682154856c5, content=偏重的研究方向：蛋白;生物材料 经验分享：请问大修是一个审稿人意见，已经返修回去，还会邀请审稿人出新的意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dbfa2580368, createdName=125a246am56暂无昵称, createdTime=Sun Aug 27 23:15:58 CST 2023, time=2023-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2229803, encodeId=e98722298037a, content=短期扩刊，这两年收稿量暴增。大概率会预警或者on hold。慎投，毕竟一篇文章不容易~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41145088522, createdName=145ca8c9m65(暂无昵称), createdTime=Tue Oct 08 14:02:47 CST 2024, time=2024-10-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2229468, encodeId=51942229468d7, content=这个杂志出版量太大，有可能on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd578280026, createdName=ms4000000794744668, createdTime=Sat Oct 05 22:55:30 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227366, encodeId=1fb3222e36632, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：皮肤 经验分享：JNB拒稿后投的，一审大约3个月，1个审稿人小修，修回2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Sep 24 10:01:03 CST 2024, time=2024-09-24, status=1, ipAttribution=上海)]

2024-11-23 ms6000001780597345 来自广西

审稿速度:6.0
经验分享：二审2个月，找了第3个审稿人，审的最初投稿版本，用前两个审稿人的问题给我拒了，去哪说理？

20 0

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯，很快，已经接收3篇了，友好的期刊和审稿人，当然提出的修改意见很中肯，希望该期刊志能尽快跨入一区，突破5分，还会支持的！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239073, encodeId=e6a722390e3ed, content=9月28号Under Review，11月25日还在找审稿人，整整两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50061907645, createdName=ms4255114797740350, createdTime=Mon Nov 25 15:38:06 CST 2024, time=2024-11-25, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2238647, encodeId=67a7223864e06, content=审稿速度:6.0 经验分享：二审2个月，找了第3个审稿人，审的最初投稿版本，用前两个审稿人的问题给我拒了，去哪说理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6a8350383, createdName=ms6000001780597345, createdTime=Sat Nov 23 12:21:10 CST 2024, time=2024-11-23, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154856, encodeId=0d682154856c5, content=偏重的研究方向：蛋白;生物材料 经验分享：请问大修是一个审稿人意见，已经返修回去，还会邀请审稿人出新的意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dbfa2580368, createdName=125a246am56暂无昵称, createdTime=Sun Aug 27 23:15:58 CST 2023, time=2023-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2229803, encodeId=e98722298037a, content=短期扩刊，这两年收稿量暴增。大概率会预警或者on hold。慎投，毕竟一篇文章不容易~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41145088522, createdName=145ca8c9m65(暂无昵称), createdTime=Tue Oct 08 14:02:47 CST 2024, time=2024-10-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2229468, encodeId=51942229468d7, content=这个杂志出版量太大，有可能on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd578280026, createdName=ms4000000794744668, createdTime=Sat Oct 05 22:55:30 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227366, encodeId=1fb3222e36632, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：皮肤 经验分享：JNB拒稿后投的，一审大约3个月，1个审稿人小修，修回2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Sep 24 10:01:03 CST 2024, time=2024-09-24, status=1, ipAttribution=上海)]

2023-08-27 125a246am56暂无昵称来自安徽省

偏重的研究方向：蛋白;生物材料
经验分享：请问大修是一个审稿人意见，已经返修回去，还会邀请审稿人出新的意见吗？

122 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯，很快，已经接收3篇了，友好的期刊和审稿人，当然提出的修改意见很中肯，希望该期刊志能尽快跨入一区，突破5分，还会支持的！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239073, encodeId=e6a722390e3ed, content=9月28号Under Review，11月25日还在找审稿人，整整两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50061907645, createdName=ms4255114797740350, createdTime=Mon Nov 25 15:38:06 CST 2024, time=2024-11-25, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2238647, encodeId=67a7223864e06, content=审稿速度:6.0 经验分享：二审2个月，找了第3个审稿人，审的最初投稿版本，用前两个审稿人的问题给我拒了，去哪说理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6a8350383, createdName=ms6000001780597345, createdTime=Sat Nov 23 12:21:10 CST 2024, time=2024-11-23, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154856, encodeId=0d682154856c5, content=偏重的研究方向：蛋白;生物材料 经验分享：请问大修是一个审稿人意见，已经返修回去，还会邀请审稿人出新的意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dbfa2580368, createdName=125a246am56暂无昵称, createdTime=Sun Aug 27 23:15:58 CST 2023, time=2023-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2229803, encodeId=e98722298037a, content=短期扩刊，这两年收稿量暴增。大概率会预警或者on hold。慎投，毕竟一篇文章不容易~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41145088522, createdName=145ca8c9m65(暂无昵称), createdTime=Tue Oct 08 14:02:47 CST 2024, time=2024-10-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2229468, encodeId=51942229468d7, content=这个杂志出版量太大，有可能on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd578280026, createdName=ms4000000794744668, createdTime=Sat Oct 05 22:55:30 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227366, encodeId=1fb3222e36632, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：皮肤 经验分享：JNB拒稿后投的，一审大约3个月，1个审稿人小修，修回2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Sep 24 10:01:03 CST 2024, time=2024-09-24, status=1, ipAttribution=上海)]

2024-10-08 145ca8c9m65(暂无昵称) 来自广东省

短期扩刊，这两年收稿量暴增。大概率会预警或者on hold。慎投，毕竟一篇文章不容易~

259 0

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯，很快，已经接收3篇了，友好的期刊和审稿人，当然提出的修改意见很中肯，希望该期刊志能尽快跨入一区，突破5分，还会支持的！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239073, encodeId=e6a722390e3ed, content=9月28号Under Review，11月25日还在找审稿人，整整两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50061907645, createdName=ms4255114797740350, createdTime=Mon Nov 25 15:38:06 CST 2024, time=2024-11-25, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2238647, encodeId=67a7223864e06, content=审稿速度:6.0 经验分享：二审2个月，找了第3个审稿人，审的最初投稿版本，用前两个审稿人的问题给我拒了，去哪说理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6a8350383, createdName=ms6000001780597345, createdTime=Sat Nov 23 12:21:10 CST 2024, time=2024-11-23, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154856, encodeId=0d682154856c5, content=偏重的研究方向：蛋白;生物材料 经验分享：请问大修是一个审稿人意见，已经返修回去，还会邀请审稿人出新的意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dbfa2580368, createdName=125a246am56暂无昵称, createdTime=Sun Aug 27 23:15:58 CST 2023, time=2023-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2229803, encodeId=e98722298037a, content=短期扩刊，这两年收稿量暴增。大概率会预警或者on hold。慎投，毕竟一篇文章不容易~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41145088522, createdName=145ca8c9m65(暂无昵称), createdTime=Tue Oct 08 14:02:47 CST 2024, time=2024-10-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2229468, encodeId=51942229468d7, content=这个杂志出版量太大，有可能on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd578280026, createdName=ms4000000794744668, createdTime=Sat Oct 05 22:55:30 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227366, encodeId=1fb3222e36632, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：皮肤 经验分享：JNB拒稿后投的，一审大约3个月，1个审稿人小修，修回2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Sep 24 10:01:03 CST 2024, time=2024-09-24, status=1, ipAttribution=上海)]

2024-10-05 ms4000000794744668 来自广东省

这个杂志出版量太大，有可能on hold

47 0

[GetPortalCommentsPageByObjectIdResponse(id=2157119, encodeId=e113215e1190b, content=偏重的研究方向：分子生物学 经验分享：投稿第三天直接decision in process 请问这是直接拒稿吗？有没有相同经历的人麻烦分享一下谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/6ntVHaKIrYflbNlrQKh1D8Sf0QGhuGiaUls32f7GwMpYBjWCRAuGp5aOB1yIN6zrJJognTELqVZFKAsy8WMLTqA/132, createdBy=aafc2336762, createdName=Markxiao, createdTime=Mon Sep 11 12:55:19 CST 2023, time=2023-09-11, status=1, ipAttribution=香港), GetPortalCommentsPageByObjectIdResponse(id=2248748, encodeId=160e2248e48f8, content=一审14个月，一直跟我说审稿人还缺一个，我到底要不要撤稿，耽误太久太久了！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0c375142848, createdName=1467d47dm55暂无昵称, createdTime=Sun Jan 19 07:34:14 CST 2025, time=2025-01-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2162463, encodeId=8ce221624639f, content=投稿7个月了，外审时间都半年了，催了几次回复都一样。问一下大家，是不是审稿人不回复，编辑就一直等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rRiaicFp2D5Zialtibib5bH8Xicoiaa0UkU4YtcrrAfpFuwiaAlBPjztFLu3icxdzV1zkf1wYjZRbfdCsLEUtic5XuGWY1HQ/132, createdBy=b6f92385679, createdName=superzera, createdTime=Thu Oct 12 21:40:23 CST 2023, time=2023-10-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=858882, encodeId=d4a9858882d1, content=嗯，很快，已经接收3篇了，友好的期刊和审稿人，当然提出的修改意见很中肯，希望该期刊志能尽快跨入一区，突破5分，还会支持的！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48345414140, createdName=ms7269483029162029, createdTime=Sun Mar 29 11:19:51 CST 2020, time=2020-03-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239073, encodeId=e6a722390e3ed, content=9月28号Under Review，11月25日还在找审稿人，整整两个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=50061907645, createdName=ms4255114797740350, createdTime=Mon Nov 25 15:38:06 CST 2024, time=2024-11-25, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=2238647, encodeId=67a7223864e06, content=审稿速度:6.0 经验分享：二审2个月，找了第3个审稿人，审的最初投稿版本，用前两个审稿人的问题给我拒了，去哪说理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6a8350383, createdName=ms6000001780597345, createdTime=Sat Nov 23 12:21:10 CST 2024, time=2024-11-23, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2154856, encodeId=0d682154856c5, content=偏重的研究方向：蛋白;生物材料 经验分享：请问大修是一个审稿人意见，已经返修回去，还会邀请审稿人出新的意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=122, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dbfa2580368, createdName=125a246am56暂无昵称, createdTime=Sun Aug 27 23:15:58 CST 2023, time=2023-08-27, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2229803, encodeId=e98722298037a, content=短期扩刊，这两年收稿量暴增。大概率会预警或者on hold。慎投，毕竟一篇文章不容易~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=259, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41145088522, createdName=145ca8c9m65(暂无昵称), createdTime=Tue Oct 08 14:02:47 CST 2024, time=2024-10-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2229468, encodeId=51942229468d7, content=这个杂志出版量太大，有可能on hold, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd578280026, createdName=ms4000000794744668, createdTime=Sat Oct 05 22:55:30 CST 2024, time=2024-10-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227366, encodeId=1fb3222e36632, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：皮肤 经验分享：JNB拒稿后投的，一审大约3个月，1个审稿人小修，修回2个月接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/05/22/ca57c1c0c773c75300bbd8ed1699ece1.jpg, createdBy=6c7e2032247, createdName=小胖子罗军, createdTime=Tue Sep 24 10:01:03 CST 2024, time=2024-09-24, status=1, ipAttribution=上海)]

2024-09-24 小胖子罗军来自上海

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：皮肤
经验分享：JNB拒稿后投的，一审大约3个月，1个审稿人小修，修回2个月接受

41 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务